CLINICAL_TRIALS
research
· 2026-02-05
Clinical Trial Update: Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer [Phase 2]
Summary
Phase 2 trial update describes hypofractionated radiotherapy with a focal microboost for high-risk and locally advanced prostate cancer. The study is currently …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Medical University of South Carolina | Conditions: Prostate Cancer, Prostate Cancer Patients Treated by Radiotherapy | Phase 2 | Status: RECRUITING